Monopar Therapeutics Inc's total assets for Q1 2025 were $55.09B, an increase of 91265.63% from the previous quarter. MNPR total liabilities were $1.49B for the fiscal quarter, a 28295.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.